Zenosense, Inc.: MIDS Medical Engages Future Diagnostics for Assay Consulting Services

Press release Mar 28, 2017 OTC Disclosure & News Service Zenosense, Inc.: MIDS Medical Engages Future Diagnostics for Assay Consulting Services VALENCIA, SPAIN–(Marketwired – Mar 28, 2017) – Zenosense, Inc. (OTCQB: ZENO) (“Zenosense”, the “Company”), a healthcare technology company primarily focused on the development and commercialization of MIDS Cardiac™, a Point of Care (“POC”) handheld…